82 related articles for article (PubMed ID: 9144533)
1. Purification of the putative coxsackievirus B receptor from HeLa cells.
Carson SD; Chapman NN; Tracy SM
Biochem Biophys Res Commun; 1997 Apr; 233(2):325-8. PubMed ID: 9144533
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
3. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
4. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
5. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells.
Chung SK; Kim JY; Kim IB; Park SI; Paek KH; Nam JH
Virology; 2005 Mar; 333(1):31-40. PubMed ID: 15708590
[TBL] [Abstract][Full Text] [Related]
6. The human fatty acid synthase: a new therapeutic target for coxsackievirus B3-induced diseases?
Rassmann A; Henke A; Jarasch N; Lottspeich F; Saluz HP; Munder T
Antiviral Res; 2007 Nov; 76(2):150-8. PubMed ID: 17662476
[TBL] [Abstract][Full Text] [Related]
7. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
8. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
[TBL] [Abstract][Full Text] [Related]
9. Long-term cardiac gene expression using a coxsackieviral vector.
Lim BK; Shin JO; Lee SC; Kim DK; Choi DJ; Choe SC; Knowlton KU; Jeon ES
J Mol Cell Cardiol; 2005 May; 38(5):745-51. PubMed ID: 15850568
[TBL] [Abstract][Full Text] [Related]
10. Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.
Carson SD; Chapman NM; Hafenstein S; Tracy S
J Virol; 2011 Apr; 85(7):3306-14. PubMed ID: 21270163
[TBL] [Abstract][Full Text] [Related]
11. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.
Chapman NM; Kim KS; Tracy S; Jackson J; Höfling K; Leser JS; Malone J; Kolbeck P
J Virol; 2000 Sep; 74(17):7952-62. PubMed ID: 10933703
[TBL] [Abstract][Full Text] [Related]
12. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
13. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
14. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease.
Liu P; Aitken K; Kong YY; Opavsky MA; Martino T; Dawood F; Wen WH; Kozieradzki I; Bachmaier K; Straus D; Mak TW; Penninger JM
Nat Med; 2000 Apr; 6(4):429-34. PubMed ID: 10742150
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
17. Receptor proteins on newborn Balb/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells.
Xu R; Mohanty JG; Crowell RL
Virus Res; 1995 Mar; 35(3):323-40. PubMed ID: 7785319
[TBL] [Abstract][Full Text] [Related]
18. Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model.
Kim YJ; Yun SH; Lim BK; Park KB; Na HN; Jeong SY; Kim DS; Cho YJ; Jeon ES; Nam JH
J Microbiol Biotechnol; 2009 Mar; 19(3):307-13. PubMed ID: 19349757
[TBL] [Abstract][Full Text] [Related]
19. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
Lee C; Maull E; Chapman N; Tracy S; Gauntt C
J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells.
Hwang HY; Kim JY; Lim JY; Chung SK; Nam JH; Park SI
Virus Res; 2007 Dec; 130(1-2):10-7. PubMed ID: 17599613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
